Fang Y - Search Results

1

A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.

Lim JQ, Huang D, Chan JY, Laurensia Y, Wong EKY, Cheah DMZ, Chia BKH, Chuang WY, Kuo MC, Su YJ, Cai QQ, Feng Y, Rao H, Feng LN, Wei PP, Chen JR, Han BW, Lin GW, Cai J, Fang Y, Tan J, Hong H, Liu Y, Zhang F, Li W, Poon MLM, Ng SB, Jeyasekharan A, Ha JCH, Khoo LP, Chin ST, Pang WL, Kee R, Cheng CL, Grigoropoulos NF, Tang T, Tao M, Farid M, Puan KJ, Xiong J, Zhao WL, Khor CC, Hwang W, Kim WS, Campo E, Tan P, Teh BT, Chng WJ, Rötzschke O, Tousseyn T, Huang HQ, Rozen S, Lim ST, Shih LY, Bei JX, Ong CK. Lim JQ, et al. Among authors: fang y. Am J Hematol. 2022 Sep;97(9):1159-1169. doi: 10.1002/ajh.26636. Epub 2022 Jul 5. Am J Hematol. 2022. PMID: 35726449 Free article.

2

Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment.

Cai Q, Fang Y, Young KH. Cai Q, et al. Among authors: fang y. Transl Oncol. 2019 Mar;12(3):523-538. doi: 10.1016/j.tranon.2018.11.011. Epub 2019 Jan 4. Transl Oncol. 2019. PMID: 30616219 Free PMC article. Review.

3

Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma.

Cai Q, Cai J, Fang Y, Young KH. Cai Q, et al. Among authors: fang y. Front Oncol. 2019 May 14;9:386. doi: 10.3389/fonc.2019.00386. eCollection 2019. Front Oncol. 2019. PMID: 31139570 Free PMC article. Review.

4

Systemic chemotherapy and sequential locoregional radiotherapy in initially metastatic nasopharyngeal carcinoma: Retrospective analysis with 821 cases.

Huang T, Su N, Zhang X, Ma S, Zhong G, Tian X, Chen Q, Tang L, Lu L, Fang Y, Cai J, Cai Q. Huang T, et al. Among authors: fang y. Head Neck. 2020 Aug;42(8):1970-1980. doi: 10.1002/hed.26130. Epub 2020 Mar 10. Head Neck. 2020. PMID: 32154638

5

BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma.

Tian XP, Cai J, Ma SY, Fang Y, Huang HQ, Lin TY, Rao HL, Li M, Xia ZJ, Kang TB, Xie D, Cai QQ. Tian XP, et al. Among authors: fang y. Cancer Commun (Lond). 2020 Jun;40(6):245-259. doi: 10.1002/cac2.12039. Epub 2020 May 27. Cancer Commun (Lond). 2020. PMID: 32459053 Free PMC article.

6

A prognostic immune risk score for diffuse large B-cell lymphoma.

Ma SY, Tian XP, Cai J, Su N, Fang Y, Zhang YC, Wang JN, Peter Gale R, Cai QQ. Ma SY, et al. Among authors: fang y. Br J Haematol. 2021 Jul;194(1):111-119. doi: 10.1111/bjh.17478. Epub 2021 May 3. Br J Haematol. 2021. PMID: 33942291

7

A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.

Cai J, Tian X, Ma S, Zhong L, Li W, Wang L, Guo L, Li Z, Wu Y, Zhong G, Huang H, Xia Z, Xia Y, Liu P, Su N, Fang Y, Zhang Y, Cai Q. Cai J, et al. Among authors: fang y. Br J Cancer. 2021 Aug;125(3):402-412. doi: 10.1038/s41416-021-01434-6. Epub 2021 May 19. Br J Cancer. 2021. PMID: 34012033 Free PMC article.

8

Comparison of chidamide-contained treatment modalities versus chemotherapy in the second-line treatment for relapsed or refractory peripheral T-cell lymphoma.

Wang J, Fang Y, Ma S, Su N, Zhang Y, Huang H, Li Z, Huang H, Tian X, Cai J, Xia Y, Liu P, Cai Q. Wang J, et al. Among authors: fang y. Leuk Res. 2021 Dec;111:106705. doi: 10.1016/j.leukres.2021.106705. Epub 2021 Sep 14. Leuk Res. 2021. PMID: 34534908

9

Optimization of high-dose methotrexate prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma: a multicenter analysis.

Fang Y, Su N, Ma S, Cai J, Zhong L, Li W, Huang H, Li Z, Huang H, Xia Y, Liu P, Guo L, Li Z, Wu Y, Tian X, Wang J, Zhang Y, Cai Q. Fang Y, et al. Ann Hematol. 2022 Mar;101(3):595-605. doi: 10.1007/s00277-021-04739-x. Epub 2022 Jan 5. Ann Hematol. 2022. PMID: 34985557

10

Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma.

Wang J, Su N, Fang Y, Ma S, Zhang Y, Cai J, Zou Q, Tian X, Xia Y, Liu P, Li Z, Huang H, Huang H, Cai Q. Wang J, et al. Among authors: fang y. Front Immunol. 2022 Feb 2;13:835103. doi: 10.3389/fimmu.2022.835103. eCollection 2022. Front Immunol. 2022. PMID: 35185926 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,990 results

Search Page